Indole as Leaving Group in the Synthesis of Annulated Pyridine Derivatives
NMR (100 MHz, CDCl3, 25 °C, TMS): δ = 42.7 (CH3), 87.5 (C-
trip), 94.1 (C-trip), 120.7, 123.4, 123.8 (CH), 126.7 (CH), 128.3
(CH), 128.4 (CH), 128.5 (CH), 131.4 (CH), 132.1 (CH), 137.9 ppm.
chromatographic purification (Et2O/pentane, 1:3) gave 0.050 g
(0.24 mmol, 98%) of 4a as a brown solid, m.p. 91–92 °C. 1H NMR
(400 MHz, CDCl3, 25 °C, TMS): δ = 7.42 (td, J = 9.2, 4.3 Hz, 1
H, H-arom.), 7.51 (t, J = 7.5 Hz, 2 H, H-arom.), 7.58 (dd, J = 11.1,
IR (neat): ν = 3055 (w), 2995 (w), 2859 (w), 2789 (w), 2212 (w),
˜
1599 (m), 1566 (m), 1545 (m), 1491 (m), 1462 (m), 1445 (m), 1423 4.0 Hz, 1 H, H-arom.), 7.69 (m, 1 H, H-arom.), 7.87 (d, J = 8.3 Hz,
(w), 1402 (w), 1273 (m), 1260 (m), 1159 (w), 1132 (w), 1096 (w), 1 H, H-arom.), 7.99 (d, J = 8.2 Hz, 1 H, H-arom.), 8.07 (s, 1 H,
1057 (s), 1042 (m), 978 (m), 922 (m), 856 (m), 816 (w), 752 (s), 692 H-arom.), 8.13 (d, J = 8.5 Hz, 2 H, H-arom.), 9.34 (s, 1 H, CHN)
(s), 629 (m), 577 (m), 554 (w), 522 (m) cm–1. HRMS (ESI): calcd. ppm. 13C NMR (100 MHz, CDCl3, 25 °C, TMS): δ = 116.5 (CH),
for C17H16N2H 249.1386; found 249.1387.
126.9 (CH), 127.0 (CH), 127.1 (CH), 127.6 (CH), 127.7, 128.5
(CH), 128.8 (CH), 130.5 (CH), 136.6, 139.6, 151.3, 152.4 (CHN)
ppm. HRMS (ESI): calcd. for C15H11NH 206.0964; found
206.0962.
1-Methyl-1-phenyl-2-[2-(phenylethynyl)benzylidene]hydrazine
(6):
From 2-(phenylethynyl)benzaldehyde (0.155 g, 0.75 mmol) and 1-
methyl-1-phenylhydrazine (0.098 g, 0.80 mmol) according to the ge-
neral procedure. The subsequent chromatographic purification
(Et2O/pentane, 1:5) gave 0.215 g (0.69 mmol, 92%) of 6 as a yellow
solid. m.p. 119–120 °C. 1H NMR (400 MHz, CDCl3, 25 °C, TMS):
δ = 3.44 (d, J = 0.6, 3 H, CH3), 6.94 (td, J = 7.3, 0.7 Hz, 1 H, H-
arom.), 7.21(td, J = 7.5, 1.0 Hz, 1 H, H-arom.), 7.29–7.41 (m, 8 H,
H-arom.), 7.50–7.55 (m, 3 H, H-arom.), 8.06 (s, 1 H, CH-imine),
8.09 (d, J = 8.0 Hz, 1 H, H-arom.) ppm. 13C NMR (100 MHz,
CDCl3, 25 °C, TMS): δ = 33.2 (CH3), 87.5 (C-trip), 94.4 (C-trip),
115.5 (CH), 120.8 (CH), 121.3, 123.3, 124.3 (CH), 127.2 (CH),
128.35 (CH), 128.43 (CH), 128.6 (CH), 129.0 (CH), 130.4 (CH),
4-(Isoquinolin-3-yl)-N,N-dimethylaniline (4b): From compound 3b
(0.050 g, 0.14 mmol) according to the general procedure. The sub-
sequent chromatographic purification (Et2O/pentane, 1:1) gave
0.022 g (0.09 mmol, 65%) of 4b as a yellow solid, m.p. 139–140 °C.
1H NMR (400 MHz, CDCl3, 25 °C, TMS): δ = 3.03 [s, 6 H,
N(CH3)2], 6.84 (dd, J = 9.5, 2.4 Hz, 2 H, H-arom.), 7.50 (m, 1 H,
H-arom.), 7.64 (m, 1 H, H-arom.), 7.81 (d, J = 8.3 Hz, 1 H, H-
arom.), 7.94 (d, J = 9.3 Hz, 1 H, H-arom.), 7.95 (s, 1 H, H-arom.),
8.05 (d, J = 9.0 Hz, 2 H, H-arom.), 9.28 (s, 1 H, CHN) ppm. 13C
NMR (100 MHz, CDCl3, 25 °C, TMS): δ = 40.4 [N(CH3)2], 112.4
(CH), 114.2 (CH), 126.1 (CH), 126.6 (CH), 127.1, 127.4, 127.6
(CH), 127.8 (CH), 130.3 (CH), 136.9, 150.8, 151.6, 152.1 (CHN)
131.4 (CH), 132.3 (CH), 137.7, 147.7 ppm. IR (neat): ν = 3076 (w),
˜
3057 (w), 3024 (w), 2216 (w), 1595 (m), 1568 (m), 1551 (m), 1493
(s), 1443 (m), 1379 (m), 1317 (m), 1275 (m), 1192 (m), 1179 (m),
1145 (m), 1090 (m), 1028 (m), 993 (m), 914 (w), 887 (m), 845 (w),
754 (s), 746 (s), 689 (s), 640 (w), 584 (m), 534 (m) cm–1. HRMS
(ESI): calcd. for C22H18N2Na 333.1362; found 333.
ppm. IR (neat): ν = 2922 (w), 2853 (w), 2804 (w), 1605 (s), 1580
˜
(s), 1524 (s), 1481 (w), 1441 (s), 1354 (s), 1321 (w), 1261 (w), 1225
(m), 1194 (s), 1167 (m), 1123 (m), 1063 (w), 1013 (w), 941 (m), 883
(s), 862 (m), 818 (s), 764 (s), 729 (m), 683 (m), 667 (m), 611 (w),
551 (m), 532 (m) cm–1. HRMS (ESI): calcd. for C17H16N2H
249.1386; found 249.1380.
N-[2-(Phenylethynyl)benzylidene]-3,4-dihydroquinolin-1(2H)-amine
(7): From 2-(phenylethynyl)benzaldehyde (0.260 g, 1.26 mmol) and
1-amino-1,2,3,4-tetrahydroquinoline (0.205 g, 1.39 mmol) accord-
ing to the general procedure. 0.215 g (0.69 mmol, 92%) of 7 as a
yellow solid, m.p. 144–145 °C. 1H NMR (400 MHz, CDCl3, 25 °C,
TMS): δ = 2.19 (m, 2 H, CH2), 2.77 (m, 2 H, CH2), 3.73 (t, J =
6.2 Hz, 2 H, CH2N), 6.82 (td, J = 7.3, 1.1 Hz, 1 H, H-arom.), 7.03
(dd, J = 7.4, 1.0 Hz, 1 H, H-arom.), 7.17–7.22 (m, 2 H, H-arom.),
7.33–7.40 (m, 4 H, H-arom.), 7.51–7.56 (m, 3 H, H-arom.), 7.80
(d, J = 8.3 Hz, 1 H, H-arom.), 8.08 (s, 1 H, CH-imine), 8.12 (dd,
J = 8.0, 0.7 Hz, 1 H, H-arom.) ppm. 13C NMR (100 MHz, CDCl3,
25 °C, TMS): δ = 21.9 (CH2), 27.0 (CH2), 44.9 (CH2), 87.5 (C-trip),
94.2 (C-trip), 114.7 (CH), 119.9 (CH), 121.2, 123.3, 123.9, 124.3
(CH), 127.1 (CH), 127.4 (CH), 128.2 (CH), 128.3 (CH), 128.4
(CH), 128.6 (CH), 129.2 (CH), 131.5 (CH), 132.4 (CH), 138.0,
3-(Thiophen-3-yl)isoquinoline (4c): From compound 3c (0.131 g,
0.40 mmol) according to the general procedure. The subsequent
chromatographic purification (Et2O/pentane, 1:3) gave 0.070 g
(0.33 mmol, 83%) of 4c as a red solid, m.p. 90–91 °C. 1H NMR
(300 MHz, CDCl3, 25 °C, TMS): δ = 7.43 (dd, J = 5.0, 3.1 Hz, 1 H,
H-arom.), 7.56 (d, J = 7.1 Hz, 1 H, H-arom.), 7.66 (t, J = 7.5 Hz, 1
H, H-arom.), 7.73 (dd, J = 5.1, 1.2 Hz, 1 H, H-arom.), 7.82 (d, J =
8.2 Hz, 1 H, H-arom.), 7.92 (s, 1 H, H-arom.), 7.94 (d, J = 8.3 Hz, 1
H, H-arom.), 8.03 (dd, J = 3.0, 1.2 Hz, 1 H, H-arom.), 9.26 (s, 1
H, CHN) ppm. 13C NMR (75 MHz, CDCl3, 25 °C, TMS): δ =
115.8 (CH), 123.1 (CH), 126.0 (CH), 126.3 (CH), 126.7 (CH), 126.8
(CH), 127.59, 127.61 (CH), 130.6 (CH), 136.6, 142.2, 147.5, 152.5
(CHN) ppm. IR (neat): ν = 3103 (w), 3053 (w), 2922 (w), 2855 (w),
˜
142.8 ppm. IR (neat): ν = 3057 (w), 3028 (w), 2938 (w), 2926 (w),
˜
1622 (m), 1582 (m), 1530 (w), 1485 (w), 1437 (m), 1379 (m), 1339
(w), 1300 (m), 1277 (m), 1229 (m), 1196 (m), 1167 (w), 1140 (w),
1013 (w), 962 (m), 945 (m), 908 (w), 881 (m), 837 (m), 804 (s), 746
(s), 691 (s), 654 (m), 617 (m), 514 (m) cm–1. HRMS (ESI): calcd. for
C13H9NSH 212.0528; found 212.0526. C13H9NS (211.28): calcd. C
73.90, H 4.29, N 6.63; found C 73.46, H 4.44, N 7.04.
2839 (w), 2141 (w), 1601 (w), 1566 (m), 1549 (w), 1485 (s), 1460
(w), 1445 (m), 1393 (s), 1277 (w), 1221 (m), 1194 (m), 1161 (s),
1074 (w), 1057 (m), 1034 (w), 1022 (w), 935 (w), 876 (w), 800 (w),
750 (s), 689 (s), 650 (w), 571 (w), 524 (m) cm–1. HRMS (ESI):
calcd. for C24H20N2Na 359.1519; found 359.1531. C24H20N2
(336.44): calcd. C 85.68, H 5.99, N 8.33; found C 85.57, H 6.07, N
8.38.
3-Hexylisoquinoline (4d): From compound 3d (0.066 g, 0.20 mmol)
according to the general procedure. The subsequent chromato-
graphic purification (Et2O/pentane, 1:3) gave 0.022 g (0.10 mmol,
General Procedure for the Silver Nitrate Assisted Cyclization of N-
{2-[Alkynyl(hetero)aryl]methylene}indolin-1-amines 3 into Annulated
Pyridine Derivatives 4: The respective N-{2-[alkynyl(hetero)aryl]-
methylene}indolin-1-amine 3 (1 mmol) was dissolved in CHCl3
(5 mL); silver nitrate (1.2 mmol; 1.2 equiv.) was added to the solu-
tion in one portion. The reaction mixture was heated at 60 °C for
the time indicated in Table 2. After cooling to room temperature,
the reaction mixture was diluted with chloroform and washed with
water. The organic phase was separated, dried with magnesium sul-
fate and purified by column chromatography.
1
52%) of 4d as an orange oil. H NMR (400 MHz, CDCl3, 25 °C,
TMS): δ = 0.88 (t, J = 7.0 Hz, 3 H, CH3.),1.31–1.41 (m, 6 H, CH2),
1.77–1.85 (m, 2 H, CH2), 2.93 (m, 2 H, CH2), 7.47 (s, 1 H, H-
arom.), 7.51–7.55 (m, 1 H, H-arom.), 7.62–7.67 (m, 1 H, H-arom.),
7.75 (d, J = 8.2 Hz, 1 H, H-arom.), 7.93 (d, J = 8.2 Hz, 1 H, H-
arom.), 9.20 (s, 1 H, CHN) ppm. 13C NMR (100 MHz, CDCl3,
25 °C, TMS): δ = 14.1 (CH3), 22.6 (CH3), 29.1 (CH3), 30.0 (CH3),
31.8 (CH3), 38.2 (CH3), 117.9 (CH), 126.1 (CH), 126.2 (CH), 127.0,
3-Phenylisoquinoline (4a):[19] From compound 3a (0.081 g, 127.5 (CH), 130.2 (CH), 152.0 (CHN), 155.9 ppm. IR (neat): ν =
˜
0.25 mmol) according to the general procedure. The subsequent
3055 (w), 2926 (m), 2855 (m), 1630 (m), 1591 (m), 1582 (m), 1491
Eur. J. Org. Chem. 2010, 1787–1797
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1795